G9a knockdown (shG9a) or activity inhibition in alveolar rhabdomyosarcoma (ARMS) upregulated PTEN, reduced phosphorylation of AKT, and decreased RAC1 activity, resulting in a decrease in cell proliferation and defective cell migration. This evidence concerns the gene AKT1 and alveolar rhabdomyosarcoma.